Los Angeles, CA, January 8, 2010 – An alliance between Probi, a leading player in probiotics research and a partner of Institut Rosell, and Jarrow Formulas, now gives the nutritional supplement company the right to sell a dietary supplement that contains Probi’s bacteria, Lp299v, exclusively to US health food stores. The Jarrow Formulas’ product Ideal Bowel Support (IBS) 299v® will launch in the first quarter of 2010.
Probi’s probiotic bacteria Lp299v has been shown in clinical trials to help people suffering from symptoms associated with Irritable Bowel Syndrome (IBS), which include diarrhea, constipation, and abdominal cramps. IBS affects up to 55 million Americans and mostly women.
“The agreement with Jarrow Formulas is another very important step in our company’s strategy to make Lp299v available on a global scale,” says Michael Oredsson, CEO at Probi. “The US is a big, important and growing market for probiotic dietary supplements. We are very pleased to launch Lp299v in the U.S. health food channel. Jarrow Formulas is one of the leading players in the probiotic category. Jarrow’s mission is to promote optimal health with high quality, effective, affordable and ‘cutting edge’ formulations, which are based on sound scientific research data. This philosophy is in line with the high quality of Lp299v.”
The U.S. probiotic dietary supplement market is estimated at approximately $500 million annually and is expected to see further growth as more high quality and clinically documented products, such as Jarrow Formulas’ product IBS 299v®, are launched. Dietary supplements that contain Probi’s probiotics are now sold or in the process of being launched in more than 30 countries worldwide.
“We will continue to work both independently and together with Institut Rosell to further expand distribution and sales of dietary supplements based on Lp299v”, says Oredsson.
Probi is a leading player in probiotics research and the developers of efficient and well-documented probiotics. Research areas include the gastrointestinal tract, immune system, metabolic syndrome, and stress and recovery. Probi’s customers are industry leaders in the functional foods and dietary supplement arena. For more information, access www.probi.com.
Institut Rosell is a French Canadian company specializing in the selection, development, production, and marketing of probiotic formulations for human nutrition and health. Expert in live microorganisms since 1934, Institut Rosell undertakes ambitious research programs to better understand the properties, modes of action, and beneficial effects on health of these probiotic formulations. Institut Rosell is part of the Lallemand Group, a privately owned company with offices in Montreal, Canada, and Toulouse, France, and production facilities in various countries around the world. For more information, access www.institut-rosell.com or e-mail email@example.com
Jarrow Formulas is a nutritional supplement formulator and marketer founded in 1977 and incorporated in 1988. The company markets its products throughout the United States and internationally in more than 20 countries in Europe, Asia, Israel and Latin America. The company offers a complete line of nutritional products that includes vitamins, minerals, probiotics, standardized herbal concentrates, amino acids, enzymes and enteral nutrition formulations. Jarrow Formulas, Inc. is active in regulatory affairs, helping to maintain American’s rights to free access to dietary supplements. Its products are manufactured by Jarrow Industries Incorporated, a pharmaceutical quality facility located in Santa Fe Springs, CA. For more information, contact Mark Becker, Director, Advertising/Communications toll free at (800) 726-0886 or access the Jarrow Formulas Web site at www.Jarrow.com.
For free Jarrow Formulas’ samples, access www.Jarrow.com/sample.
Michael Oredsson, CEO Probi
Phone: +46 46 286 89 23
Niklas Bjärum, VP Marketing & Sales, Probi
Phone: +46 46 286 89
Olivier Clech, President, Institut Rosell
Phone: +33 611 30 26 31
Peilin Guo, EVP, Jarrow Formulas